Cargando…

Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL

Detalles Bibliográficos
Autores principales:	Yalcinkaya, Mustafa, von Eckardstein, Arnold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171970/ https://www.ncbi.nlm.nih.gov/pubmed/32312902 http://dx.doi.org/10.2337/dbi20-0005

Ejemplares similares

HDL, heart disease, and the lung
por: Frey, Kathrin, et al.
Publicado: (2022)

Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate
por: Kobayashi, Tamaki, et al.
Publicado: (2021)

Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes
por: Christensen, Pernille M., et al.
Publicado: (2017)

HDL-bound sphingosine 1-phosphate restrains lymphopoiesis and neuroinflammation
por: Blaho, Victoria A., et al.
Publicado: (2015)

HDL – Quo vadis
por: von Eckardstein, Arnold, et al.
Publicado: (2023)

Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases
por: Diarte-Añazco, Elena M. G., et al.
Publicado: (2019)

The Apolipoprotein M–Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis
por: Arkensteijn, Bas W. C., et al.
Publicado: (2013)

Sphingosine 1‐phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons
por: Frej, Cecilia, et al.
Publicado: (2016)

Apolipoprotein M Inhibits Angiogenic and Inflammatory Response by Sphingosine 1-Phosphate on Retinal Pigment Epithelium Cells
por: Terao, Ryo, et al.
Publicado: (2017)

Apolipoprotein M-bound sphingosine-1-phosphate regulates blood–brain barrier paracellular permeability and transcytosis
por: Mathiesen Janiurek, Mette, et al.
Publicado: (2019)

Association of apolipoprotein M and sphingosine-1-phosphate with brown adipose tissue after cold exposure in humans
por: Borup, Anna, et al.
Publicado: (2022)

Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia
por: Juhász, Lilla, et al.
Publicado: (2022)

Sphingosine 1-phosphate escapes the Catch-22 of sepsis prevention and mitigation therapies
por: Blaho, Victoria A.
Publicado: (2020)

Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice
por: Nojiri, Takahiro, et al.
Publicado: (2014)

The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions
por: Robert, Jérôme, et al.
Publicado: (2021)

Importance of Apolipoprotein A-I and A-II Composition in HDL and Its Potential for Studying COVID-19 and SARS-CoV-2
por: Cho, Kyung-Hyun
Publicado: (2021)

Transport of Apolipoprotein B-Containing Lipoproteins through Endothelial Cells Is Associated with Apolipoprotein E-Carrying HDL-Like Particle Formation
por: Yang, Hong, et al.
Publicado: (2018)

Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway
por: Izquierdo, María Concepción, et al.
Publicado: (2022)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Frail HDLs and Stiff Arteries in Type 2 Diabetes in Juveniles
por: von Eckardstein, Arnold, et al.
Publicado: (2013)

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids
por: Othman, Alaa, et al.
Publicado: (2023)

HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
por: Ruiz, Mario, et al.
Publicado: (2017)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023)

Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation
por: Yalcinkaya, Ahmet, et al.
Publicado: (2019)

HDL Cholesterol Story Is Dead: Long Live HDL!
por: Simha, Vinaya, et al.
Publicado: (2016)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
por: Winkler, Martin Sebastian, et al.
Publicado: (2019)

Apolipoprotein M - a new biomarker in sepsis
por: Christoffersen, Christina, et al.
Publicado: (2012)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Sphingosine-1-phosphate: Driver of NFκB and STAT3 persistent activation in chronic intestinal inflammation and colitis-associated cancer
por: Theiss, Arianne L
Publicado: (2013)

The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions
por: Furberg, Curt D
Publicado: (2001)

Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice
por: den Hoedt, Sandra, et al.
Publicado: (2021)

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
por: Ceccom, Johnatan, et al.
Publicado: (2014)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

Hyperglycemia‐Triggered Sphingosine‐1‐Phosphate and Sphingosine‐1‐Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization
por: Hu, Yuanchang, et al.
Publicado: (2019)

HDL cholesterol: reappraisal of its clinical relevance
por: März, Winfried, et al.
Publicado: (2017)

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate
por: Mishima, Yuko, et al.
Publicado: (2018)

Irisin Is Target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated Signaling in Skeletal Muscle Cells
por: Pierucci, Federica, et al.
Publicado: (2023)

Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
por: Tanaka, Yuko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ce9ds5ng0jkpaq29259krp7pq8